Who makes Valsaltan, amlodipine?

Valsaltan, amlodipine is developed by Yonsei University.

What development phase is Valsaltan, amlodipine in?

Valsaltan, amlodipine is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Valsaltan, amlodipine

Yonsei University · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Valsaltan, amlodipine
Sponsor	Yonsei University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Valsaltan, amlodipine CI brief — competitive landscape report
Valsaltan, amlodipine updates RSS · CI watch RSS
Yonsei University portfolio CI